According to cognitive market research, the global botanical drug market size was USD 169.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 40.30% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 67.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 38.5% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 50.88 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 39.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 42.3% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 8.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 39.7% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 3.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 40.0% from 2024 to 2031.
The standardized extracts held the highest Botanical Drug market revenue share in 2024.
